Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 7/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6855700 | 0.81 | AVPR1B (0.49) | AVPR1BHRH3ATM | |
| SCHEMBL6856267 | 0.79 | AVPR1B (0.46) | AVPR1BHRH3 | |
| SCHEMBL6857409 | 0.79 | AVPR1B (0.43) | AVPR1B | |
| SCHEMBL6857474 | 0.79 | AVPR1B (0.45) | AVPR1BHRH3 | |
| SCHEMBL6857383 | 0.78 | AVPR1B (0.42) | AVPR1B | |
| SCHEMBL6856882 | 0.78 | AVPR1B (0.52) | AVPR1BHRH3 | |
| SCHEMBL6856761 | 0.76 | AVPR1B (0.41) | AVPR1B | |
| SCHEMBL6856915 | 0.75 | AVPR1B (0.40) | AVPR1BTLR7 | |
| SCHEMBL6856256 | 0.74 | AVPR1B (0.52) | AVPR1B | |
| SCHEMBL6857488 | 0.74 | HRH3 (0.47) | AVPR1BHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011096461-A1 | QUINOLINE DERIVATIVE | 大正製薬株式会社 (JP) | 2011-08-11 | — | — | WO | disclosed |